TuHURA Biosciences, Inc./NV SEC filings HURA
TuHURA Biosciences, Inc./NV has 928 filings in SEC EDGAR's recent list, going back to Aug 17, 2010. Its latest annual report, Form ARS, was filed on Jul 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (new debt). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Apr 8, 2026 | — |
| 424B5 | Prospectus supplement | Dec 10, 2025 | — |
| 424B3 | Prospectus | Nov 25, 2025 | — |
| S-3 | Shelf registration | Nov 3, 2025 | — |
| 424B3 | Prospectus | Oct 31, 2025 | — |
| 424B3 | Prospectus | Sep 26, 2025 | — |
| S-1/A | Amended registration statement | Sep 18, 2025 | — |
| S-1 | Registration statement | Aug 12, 2025 | — |
| 424B3 | Prospectus | May 23, 2025 | — |
| S-4/A | Filing | May 8, 2025 | — |
| S-4/A | Filing | May 6, 2025 | — |
| S-4 | Registration for a merger or exchange | Feb 7, 2025 | — |
| S-8 | Employee stock plan registration | Dec 23, 2024 | — |
| POS AM | Filing | Oct 8, 2024 | — |
| 424B3 | Prospectus | Sep 25, 2024 | — |
| 424B3 | Prospectus | Aug 19, 2024 | — |
| S-4/A | Filing | Aug 12, 2024 | — |
| S-4/A | Filing | Aug 8, 2024 | — |
| S-4/A | Filing | Jul 19, 2024 | — |
| S-4/A | Filing | Jun 27, 2024 | — |
| S-4 | Registration for a merger or exchange | May 13, 2024 | — |
| 424B5 | Prospectus supplement | Dec 18, 2023 | — |
| S-1/A | Amended registration statement | Oct 27, 2023 | — |
| S-1/A | Amended registration statement | Oct 24, 2023 | — |
| S-1 | Registration statement | Oct 4, 2023 | — |
| 424B5 | Prospectus supplement | Sep 19, 2023 | — |
| S-8 | Employee stock plan registration | Sep 27, 2022 | — |
| 424B5 | Prospectus supplement | Aug 3, 2022 | — |
| 424B5 | Prospectus supplement | Apr 13, 2022 | — |
| S-8 | Employee stock plan registration | Sep 28, 2021 | — |
| 424B5 | Prospectus supplement | Sep 27, 2021 | — |
| S-3 | Shelf registration | Mar 24, 2021 | — |
| 424B4 | Prospectus | Nov 4, 2020 | — |
| S-3 | Shelf registration | Oct 26, 2020 | — |
| S-8 | Employee stock plan registration | Sep 21, 2020 | — |
| 424B3 | Prospectus | Jul 2, 2020 | — |
| S-4/A | Form s-4/a | Jul 2, 2020 | — |
| S-4 | Registration for a merger or exchange | Jun 16, 2020 | — |
| 424B4 | Prospectus | Nov 21, 2019 | — |
| 424B4 | Prospectus | Nov 21, 2019 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | Nov 15, 2019 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | Nov 15, 2019 | — |
| 424B4 | Prospectus | Aug 15, 2019 | — |
| S-1/A | Amended registration statement | Aug 12, 2019 | — |
| S-1 | Registration statement | Aug 1, 2019 | — |
| 424B4 | Prospectus | Jul 17, 2019 | — |
| S-1/A | Amended registration statement | Jul 11, 2019 | — |
| S-1 | Registration statement | Jun 25, 2019 | — |
| POS AM | Post-effective amendment no. 1 | Jun 10, 2019 | — |
| 424B5 | Prospectus supplement | Jun 4, 2019 | — |
| 424B3 | Prospectus | May 31, 2019 | — |
| 424B4 | Prospectus | May 30, 2019 | — |
| 424B4 | Prospectus | May 29, 2019 | — |
| S-1/A | Amended registration statement | May 23, 2019 | — |
| S-1/A | Amended registration statement | May 8, 2019 | — |
| S-1 | Registration statement | Apr 18, 2019 | — |
| 424B3 | Prospectus | Feb 19, 2019 | — |
| S-3 | Shelf registration | Dec 26, 2018 | — |
| 424B5 | Prospectus supplement | Nov 26, 2018 | — |
| 424B5 | Prospectus supplement | Sep 22, 2017 | — |
| 424B5 | Prospectus supplement | Sep 22, 2017 | — |
| 424B5 | Prospectus supplement | Apr 14, 2017 | — |
| 424B5 | Prospectus supplement | Apr 12, 2017 | — |
| 424B3 | Prospectus | Sep 29, 2016 | — |
| 424B3 | Prospectus | Sep 28, 2016 | — |
| POS AM | Post-effective amendment no. 4 to form s-1 | Sep 13, 2016 | — |
| S-3 | Shelf registration | Sep 13, 2016 | — |
| S-3 | Shelf registration | Sep 13, 2016 | — |
| 424B5 | Prospectus supplement | Dec 30, 2015 | — |
| 424B3 | Prospectus | Dec 1, 2015 | — |
| POS AM | Post-effective amendment no.3 for registration statement | Nov 20, 2015 | — |
| 424B3 | Prospectus | Jul 15, 2015 | — |
| S-1/A | Amended registration statement | Jul 15, 2015 | — |
| S-1/A | Amended registration statement | Jul 9, 2015 | — |
| S-1/A | Amended registration statement | Jun 30, 2015 | — |
| S-1/A | Amended registration statement | Jun 23, 2015 | — |
| S-1/A | Amended registration statement | Jun 12, 2015 | — |
| S-1/A | Amended registration statement | May 14, 2015 | — |
| S-1/A | Amended registration statement | May 12, 2015 | — |
| S-1/A | Amended registration statement | May 12, 2015 | — |
| S-1/A | Amended registration statement | May 7, 2015 | — |
| S-1/A | Amended registration statement | Apr 21, 2015 | — |
| S-1 | Registration statement | Apr 10, 2015 | — |
| 424B3 | Prospectus | Mar 16, 2015 | — |
| POS AM | Delmar pharmaceuticals, inc. form pos am | Mar 6, 2015 | — |
| 424B3 | Prospectus | Feb 10, 2015 | — |
| 424B3 | Prospectus | Jan 8, 2015 | — |
| 424B3 | Prospectus | Nov 6, 2014 | — |
| 424B3 | Prospectus | Aug 12, 2014 | — |
| 424B3 | Prospectus | Jun 9, 2014 | — |
| 424B3 | Prospectus | Apr 29, 2014 | — |
| POS AM | Delmar pharmaceuticals, inc. form pos am | Apr 17, 2014 | — |
| 424B3 | Prospectus | Jun 28, 2013 | — |
| S-1 | Registration statement | Jun 14, 2013 | — |
| S-1/A | Amended registration statement | Dec 2, 2010 | — |
| S-1/A | Amended registration statement | Nov 12, 2010 | — |
| S-1/A | Amended registration statement | Oct 15, 2010 | — |
| S-1/A | Amended registration statement | Sep 23, 2010 | — |
| S-1 | Registration statement | Aug 17, 2010 | — |
Showing 99 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Tampa, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1498382
- Former names
- Kintara Therapeutics, Inc. (until Oct 22, 2024); DelMar Pharmaceuticals, Inc. (until Aug 18, 2020); Berry Only Inc. (until Jan 18, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.